Shi Yuan, Chen Ying, Hou Ying-yong, Ji Chun-hua, Hu Qin, Zhou Yang, Su Jie-akesu, Tan Yun-shan
Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Zhong Liu Za Zhi. 2011 Feb;33(2):110-4.
To study the expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP A2/B1) in non-small cell lung cancer (NSCLC), and the interaction between hnRNP A2/B1 protein and mRNA of DNA repair enzymes O(6)-methylguanine DNA-methyltransferase (MGMT), 8-oxoguanine DNA glycosylase (OGG1), redox factor 1(Ref-1), DNA-dependent protein kinase (including DNA-PKcs and ku).
The expression and distribution of hnRNP A2/B1 were detected by immunohistochemistry and Western blot on 50 NSCLC samples from patients who underwent resection in Zhongshan Hospital. The hnRNP A2/B1 mRNA expression was tested by real-time PCR. Co-immunoprecipitation (co-IP) combined RT-PCR was used to investigate whether hnRNP A2/B1 could be bound with the mRNA of the above mentioned 5 DNA repair enzymes in human lung cancer cell line (HTB-182). Then immunohistochemistry and real-time PCR were used to detect the expression of MGMT in the same group of patients.
HnRNP A2/B1 protein and mRNA expressions were increased in the NSCLC tissues than that in the corresponding normal lung tissues. HnRNP A2/B1 was expressed predominantly in the nuclei of tumor cells. The positive rate and immunohistochemistry score of hnRNP A2/B1 in tumor tissue were significantly higher than that in normal tissue (P < 0.01). In stage III-IV NSCLC, hnRNP A2/B1 expression was higher than that in stage I-II. There was no significant differences of hnRNP A2/B1 expression among patients of different age, sex, histological type, and smoking history. The results of co-IP combined RT-PCR suggested that hnRNP A2/B1 is bound with MGMT mRNA, and MGMT expression is decreased in tumor tissue of NSCLC.
The results of this study show that hnRNP A2/B1 protein and mRNA are highly expressed in NSCLC, and hnRNP A2/B1 is bound with MGMT mRNA, which indicate that it might be one of the mechanisms of hnRNP A2/B1 participating in the pathogenesis of NSCLC.
研究异质性核核糖核蛋白A2/B1(hnRNP A2/B1)在非小细胞肺癌(NSCLC)中的表达,以及hnRNP A2/B1蛋白与DNA修复酶O(6)-甲基鸟嘌呤-DNA甲基转移酶(MGMT)、8-氧代鸟嘌呤DNA糖基化酶(OGG1)、氧化还原因子1(Ref-1)、DNA依赖性蛋白激酶(包括DNA-PKcs和ku)的mRNA之间的相互作用。
采用免疫组织化学和蛋白质免疫印迹法检测50例在中山医院接受手术切除的NSCLC患者样本中hnRNP A2/B1的表达和分布。采用实时荧光定量PCR检测hnRNP A2/B1 mRNA的表达。运用免疫共沉淀(co-IP)联合RT-PCR研究在人肺癌细胞系(HTB-182)中hnRNP A2/B1是否能与上述5种DNA修复酶的mRNA结合。然后采用免疫组织化学和实时荧光定量PCR检测同一组患者中MGMT的表达。
NSCLC组织中hnRNP A2/B1蛋白和mRNA表达均高于相应的正常肺组织。hnRNP A2/B1主要在肿瘤细胞核中表达。肿瘤组织中hnRNP A2/B1的阳性率和免疫组织化学评分显著高于正常组织(P < 0.01)。在Ⅲ-Ⅳ期NSCLC中,hnRNP A2/B1表达高于Ⅰ-Ⅱ期。不同年龄、性别、组织学类型和吸烟史的患者中hnRNP A2/B1表达无显著差异。免疫共沉淀联合RT-PCR结果提示hnRNP A2/B1与MGMT mRNA结合,且NSCLC肿瘤组织中MGMT表达降低。
本研究结果表明,hnRNP A2/B1蛋白和mRNA在NSCLC中高表达,且hnRNP A2/B1与MGMT mRNA结合,这表明这可能是hnRNP A2/B1参与NSCLC发病机制的机制之一。